Canterbury DHB

Context

Herpes Simplex - Orofacial/Genital

Pathogen

Drug Treatment

Primary infection

valaciclovir

HMLSchedNZF

PO 500 mg twice a day for 5 days

OR

aciclovir

HMLSchedNZFPMLnoids

PO 400 mg three times a day for 5 days

Secondary attack (recurrence)

valaciclovir

HMLSchedNZF

PO 500 mg twice a day for 3 days

OR

aciclovir

HMLSchedNZFPMLnoids

PO 400 mg three times a day for 5 days

or PO 800 mg three times a day for 2 days

Information about this Canterbury DHB document (99253):

Document Owner:

Not assigned (see Who's Who)

Last Updated:

November 2015 (Sexually Transmitted Infections)

Next Review Due:

November 2018

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document.

Topic Code: 99253